Hannover, Germany

Kristina Rehmet



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Vaccine Development: The Contributions of Kristina Rehmet

Introduction

Kristina Rehmet, an accomplished inventor based in Hannover, Germany, has made significant strides in the field of vector vaccines. With a total of four patents to her name, Rehmet has focused her research on developing innovative solutions that enhance vaccine efficacy.

Latest Patents

One of her most notable inventions is the patent for the EHV insertion site UL43. This invention centers around the novel EHV insertion site and pertains to vector vaccines. It introduces new expression cassettes and vectors designed to express genes of interest, particularly those encoding antigen sequences. These viral vectors hold great promise for the production of immunogenic compositions and vaccines.

Rehmet has also developed a patent focusing on novel promoter sequences, which again relates to the field of vector vaccines. Similar to her previous patent, this invention involves expression cassettes and vectors applicable to expressing genes of interest, aiding in the formulation of effective immunogenic compositions.

Career Highlights

Throughout her career, Kristina Rehmet has worked at prominent organizations where she has contributed to groundbreaking research. Notably, she has been associated with Boehringer Ingelheim Vetmedica GmbH, a company known for its commitment to veterinary pharmaceuticals and biologicals.

Collaborations

Rehmet has collaborated with talented individuals, including her coworkers Alice Mundt and Andreas Gallei. Their collective efforts have undoubtedly influenced the advancements she has made in the vaccine development sector.

Conclusion

Kristina Rehmet represents the forefront of innovation in vaccine technology. Her recent patents demonstrate her dedication to enhancing vaccine development processes and offer promising avenues for immunogenic advancements. As the field continues to evolve, contributions from inventors like Rehmet will play a pivotal role in shaping effective health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…